GlassScriptPhysician profile
Mary Lee
NPI 1790396828
$5,551.01
in general payments reported to CMS, 2019-2025
43 companies · $1,434 in 2025
The $1,434 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,426 · 2022: $1,179 · 2023: $313 · 2024: $1,200 · 2025: $1,434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,946.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,033.50 | 2021-2025 | Fasenra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $578.37 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Amgen INC. | $487.19 | 2021-2025 | Otezla, Repatha, Otezla |
| Actelion Pharmaceuticals US, INC. | $440.74 | 2021-2024 | Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $351.20 | 2021-2024 | Ofev |
| Regeneron Healthcare Solutions, INC. | $349.07 | 2021-2025 | Dupixent |
| Genzyme Corporation | $256.46 | 2021-2025 | |
| Lilly USA, LLC | $170.32 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Baxter Healthcare | $162.97 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Janssen Pharmaceuticals, INC | $153.86 | 2021-2022 | |
| Novo Nordisk INC | $115.08 | 2021-2023 | |
| Grifols USA, LLC | $106.62 | 2021-2025 | Prolastin-C Liquid |
| Viatris Specialty LLC | $104.22 | 2025 | Yupelri |
| United Therapeutics Corporation | $100.17 | 2021-2025 | Tyvaso, Tyvaso |
| Mallinckrodt Hospital Products INC. | $93.52 | 2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $84.05 | 2021-2022 | |
| Abbvie INC. | $82.54 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.14 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $76.40 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $61.67 | 2022-2025 | Winrevair, Verquvo, Belsomra |
| Dexcom, INC. | $59.27 | 2021-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $52.36 | 2021 | |
| Mylan Specialty L.P. | $50.87 | 2022-2024 | Yupelri |
| Globus Medical, INC. | $46.68 | 2025 | Senza |
| Pulmonx Corporation | $38.38 | 2025 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
| Takeda Pharmaceuticals U.S.A., INC. | $38.35 | 2021 | |
| Paratek Pharmaceuticals, INC. | $33.77 | 2022-2023 | Nuzyra |
| Pfizer INC. | $33.52 | 2021-2025 | |
| Verona Pharma, INC. | $31.35 | 2025 | Ohtuvayre |
| Insulet Corporation | $28.90 | 2021-2023 | Omnipod |
| Sunovion Pharmaceuticals INC. | $27.50 | 2021 | |
| Abbott Laboratories | $27.47 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $25.87 | 2021-2022 | |
| Aurinia Pharma U.S., INC. | $25.58 | 2023 | Lupkynis |
| Xeris Pharmaceuticals, INC. | $20.26 | 2025 | Gvoke Hypopen |
| Radius Health, INC. | $19.46 | 2024 | Tymlos |
| Otsuka America Pharmaceutical, INC. | $16.63 | 2025 | Rexulti |
| Philips North America LLC | $14.97 | 2022 | |
| Advanced Respiratory, INC | $14.79 | 2021 | |
| Inspire Medical Systems, INC. | $14.06 | 2025 | Inspire |
| Idorsia Pharmaceuticals US INC | $13.86 | 2025 | Quviviq |
| Axsome Therapeutics, INC. | $13.63 | 2025 | Sunosi |
| Exact Sciences Corporation | $13.39 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.